Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Toward Facilitated Self-Service in Health Care.

Asch DA, Nicholson S, Berger ML.

N Engl J Med. 2019 May 16;380(20):1891-1893. doi: 10.1056/NEJMp1817104. No abstract available.

PMID:
31091371
2.

Disturbed neurotransmitter homeostasis in ether lipid deficiency.

Dorninger F, König T, Scholze P, Berger ML, Zeitler G, Wiesinger C, Gundacker A, Pollak DD, Huck S, Just WW, Forss-Petter S, Pifl C, Berger J.

Hum Mol Genet. 2019 Jun 15;28(12):2046-2061. doi: 10.1093/hmg/ddz040.

3.

Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA.

Kristensen FB, Husereau D, Huić M, Drummond M, Berger ML, Bond K, Augustovski F, Booth A, Bridges JFP, Grimshaw J, IJzerman MJ, Jonsson E, Ollendorf DA, Rüther A, Siebert U, Sharma J, Wailoo A.

Value Health. 2019 Jan;22(1):13-20. doi: 10.1016/j.jval.2018.08.010. Epub 2018 Dec 13.

PMID:
30661627
4.

The joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making: an interview with Marc Berger.

Berger ML.

J Comp Eff Res. 2018 Jan;7(1):11-13. doi: 10.2217/cer-2017-0082. Epub 2017 Oct 20.

5.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M; joint ISPE‐ISPOR Special Task Force on Real World Evidence in Health Care Decision Making.

Value Health. 2017 Sep;20(8):1009-1022. doi: 10.1016/j.jval.2017.08.3018. Epub 2017 Sep 15. Erratum in: Value Health. 2018 Feb;21(2):248.

6.

Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.

Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Mullins CD.

Value Health. 2017 Sep;20(8):1003-1008. doi: 10.1016/j.jval.2017.08.3019. Epub 2017 Sep 15.

7.

Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.

Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, Madigan D, Makady A, Schneeweiss S, Tarricone R, Wang SV, Watkins J, Daniel Mullins C.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1033-1039. doi: 10.1002/pds.4297.

8.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M; joint ISPE-ISPOR Special Task Force on Real World Evidence in Health Care Decision Making.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1018-1032. doi: 10.1002/pds.4295. Erratum in: Pharmacoepidemiol Drug Saf. 2017 Dec;26(12 ):1570.

9.

Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database Studies.

Desai JR, Hyde CL, Kabadi S, St Louis M, Bonato V, Katrina Loomis A, Galaznik A, Berger ML.

Med Care. 2017 Mar;55(3):244-251. doi: 10.1097/MLR.0000000000000640.

10.

Big Data: transforming drug development and health policy decision making.

Alemayehu D, Berger ML.

Health Serv Outcomes Res Methodol. 2016;16:92-102. Epub 2016 Mar 5.

11.

Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.

Palomares RA, Hurley DJ, Bittar JH, Saliki JT, Woolums AR, Moliere F, Havenga LJ, Norton NA, Clifton SJ, Sigmund AB, Barber CE, Berger ML, Clark MJ, Fratto MA.

Vet Immunol Immunopathol. 2016 Oct 1;178:88-98. doi: 10.1016/j.vetimm.2016.07.003. Epub 2016 Jul 5.

PMID:
27496747
12.

Opportunities and challenges in leveraging electronic health record data in oncology.

Berger ML, Curtis MD, Smith G, Harnett J, Abernethy AP.

Future Oncol. 2016 May;12(10):1261-74. doi: 10.2217/fon-2015-0043. Epub 2016 Mar 8.

PMID:
27096309
13.

Soaping the NMDA receptor: Various types of detergents influence differently [(3)H]MK-801 binding to rat brain membranes.

Berger ML.

Biochim Biophys Acta. 2016 Jan;1858(1):116-22. doi: 10.1016/j.bbamem.2015.10.021. Epub 2015 Oct 28.

14.

Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.

Berger ML, Rebernik P.

Bioorg Med Chem Lett. 2015 Oct 1;25(19):4131-5. doi: 10.1016/j.bmcl.2015.08.017. Epub 2015 Aug 8.

PMID:
26296478
15.

Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.

Berger ML, Maciejewska D, Vanden Eynde JJ, Mottamal M, Żabiński J, Kaźmierczak P, Rezler M, Jarak I, Piantanida I, Karminski-Zamola G, Mayence A, Rebernik P, Kumar A, Ismail MA, Boykin DW, Huang TL.

Bioorg Med Chem. 2015 Aug 1;23(15):4489-500. doi: 10.1016/j.bmc.2015.06.012. Epub 2015 Jun 14.

16.

Optimizing the leveraging of real-world data to improve the development and use of medicines.

Berger ML, Lipset C, Gutteridge A, Axelsen K, Subedi P, Madigan D.

Value Health. 2015 Jan;18(1):127-30. doi: 10.1016/j.jval.2014.10.009. Epub 2014 Nov 27. Review.

17.

GABA(A) receptor subtype-selectivity of novel bicuculline derivatives.

Ramerstorfer J, Foppa V, Thiery H, Hermange P, Janody S, Berger ML, Dodd RH, Sieghart W.

Curr Med Chem. 2015;22(6):771-80.

PMID:
25386826
18.

Methoxylated PBDEs (MeO-PBDEs), hydroxylated PBDEs (HO-PBDEs) and hydroxylated PCBs (HO-PCBs) in the liver of harbor seals from the northwest Atlantic.

Weijs L, Shaw SD, Berger ML, Neels H, Blust R, Covaci A.

Sci Total Environ. 2014 Sep 15;493:606-14. doi: 10.1016/j.scitotenv.2014.06.028. Epub 2014 Jun 28.

PMID:
24982026
19.

Polychlorinated biphenyls still pose significant health risks to northwest Atlantic harbor seals.

Shaw SD, Berger ML, Weijs L, Päpke O, Covaci A.

Sci Total Environ. 2014 Aug 15;490:477-87. doi: 10.1016/j.scitotenv.2014.05.011. Epub 2014 May 27.

PMID:
24875260
20.

Big data, advanced analytics and the future of comparative effectiveness research.

Berger ML, Doban V.

J Comp Eff Res. 2014 Mar;3(2):167-76. doi: 10.2217/cer.14.2.

PMID:
24645690
21.

A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.

Berger ML, Martin BC, Husereau D, Worley K, Allen JD, Yang W, Quon NC, Mullins CD, Kahler KH, Crown W.

Value Health. 2014 Mar;17(2):143-56. doi: 10.1016/j.jval.2013.12.011. Erratum in: Value Health. 2014 Jun;17(4):489.

22.

[The district Weinheim nursing home in national socialism].

Berger ML.

Hist Hosp. 2014-2015;29:517-30. German. No abstract available.

PMID:
27501574
23.

Interview: access to richer data promises to usher in a new era of insight into patient heterogeneity.

Berger ML.

J Comp Eff Res. 2013 Mar;2(2):109-12. doi: 10.2217/cer.13.5. No abstract available.

24.

Can the pharmaceutical industry embrace comparative effectiveness research? A view from inside.

Berger ML.

Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):565-8. doi: 10.1586/14737167.2013.833061. Epub 2013 Oct 3. No abstract available.

PMID:
24090045
25.

Holographic quantitative structure-activity relationships of tryptamine derivatives at NMDA, 5HT(1A) and 5HT(2A) receptors.

Palangsuntikul R, Berner H, Berger ML, Wolschann P.

Molecules. 2013 Jul 24;18(8):8799-811. doi: 10.3390/molecules18088799.

26.

Persistent organic pollutants including polychlorinated and polybrominated dibenzo-p-dioxins and dibenzofurans in firefighters from Northern California.

Shaw SD, Berger ML, Harris JH, Yun SH, Wu Q, Liao C, Blum A, Stefani A, Kannan K.

Chemosphere. 2013 Jun;91(10):1386-94. doi: 10.1016/j.chemosphere.2012.12.070. Epub 2013 Feb 8. Erratum in: Chemosphere. 2014 May;102:87.

PMID:
23395527
27.

[(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes.

Berger ML, Hammerschmidt F, Qian R, Hahner S, Schirbel A, Stichelberger M, Schibli R, Yu J, Arion VB, Woschek A, Öhler E, Zolle IM.

Mol Pharm. 2013 Mar 4;10(3):1119-30. doi: 10.1021/mp3006227. Epub 2013 Feb 20.

PMID:
23343186
28.

Development and automation of a novel NET-PET tracer: [11C]Me@APPI.

Mark C, Bornatowicz B, Mitterhauser M, Hendl M, Nics L, Haeusler D, Lanzenberger R, Berger ML, Spreitzer H, Wadsak W.

Nucl Med Biol. 2013 Feb;40(2):295-303. doi: 10.1016/j.nucmedbio.2012.11.009. Epub 2012 Dec 21.

PMID:
23265665
29.

Exploring the polyamine regulatory site of the NMDA receptor: a parallel synthesis approach.

Berger ML, Pöhler T, Schadt O, Stanger M, Rebernik P, Scholze P, Noe CR.

ChemMedChem. 2013 Jan;8(1):82-94. doi: 10.1002/cmdc.201200470. Epub 2012 Dec 6.

PMID:
23225329
30.

The view of a model user on the ISPOR-SMDM modeling good research task force report.

Berger ML.

Value Health. 2012 Sep-Oct;15(6):794-5. doi: 10.1016/j.jval.2012.04.003. No abstract available.

31.

Screening of 64 tryptamines at NMDA, 5-HT1A, and 5-HT2A receptors: a comparative binding and modeling study.

Berger ML, Palangsuntikul R, Rebernik P, Wolschann P, Berner H.

Curr Med Chem. 2012;19(18):3044-57.

PMID:
22519402
32.

Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.

Berger ML, Dreyer N, Anderson F, Towse A, Sedrakyan A, Normand SL.

Value Health. 2012 Mar-Apr;15(2):217-30. doi: 10.1016/j.jval.2011.12.010.

33.

The role of private industry in pragmatic comparative effectiveness trials.

Buesching DP, Luce BR, Berger ML.

J Comp Eff Res. 2012 Mar;1(2):147-56. doi: 10.2217/cer.12.9. Review.

PMID:
24237375
34.

Tissue-specific accumulation of polybrominated diphenyl ethers (PBDEs) including Deca-BDE and hexabromocyclododecanes (HBCDs) in harbor seals from the northwest Atlantic.

Shaw SD, Berger ML, Weijs L, Covaci A.

Environ Int. 2012 Sep;44:1-6. doi: 10.1016/j.envint.2012.01.001. Epub 2012 Feb 7.

PMID:
22321537
35.

Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.

Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C.

Neuroscience. 2011 Apr 28;180:280-92. doi: 10.1016/j.neuroscience.2011.02.017. Epub 2011 Feb 16.

PMID:
21333719
36.

Comparative effectiveness research: the view from a pharmaceutical company.

Berger ML, Grainger D.

Pharmacoeconomics. 2010;28(10):915-22. doi: 10.2165/11535400-000000000-00000.

PMID:
20831299
37.

GRACE principles: recognizing high-quality observational studies of comparative effectiveness.

Dreyer NA, Schneeweiss S, McNeil BJ, Berger ML, Walker AM, Ollendorf DA, Gliklich RE; GRACE Initiative.

Am J Manag Care. 2010 Jun;16(6):467-71.

38.

Raising the bar of efficacy for drug approval requires an understanding of patient diversity.

Berger ML, Eck S, Ruberg SJ.

J Clin Oncol. 2010 Jul 10;28(20):e343-4; author reply e345. doi: 10.1200/JCO.2010.28.2475. Epub 2010 May 10. No abstract available.

PMID:
20458030
40.

Structure-activity relationship of etomidate derivatives at the GABA(A) receptor: Comparison with binding to 11beta-hydroxylase.

Atucha E, Hammerschmidt F, Zolle I, Sieghart W, Berger ML.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4284-7. doi: 10.1016/j.bmcl.2009.05.065. Epub 2009 May 24.

PMID:
19497738
41.

NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.

Berger ML, Schweifer A, Rebernik P, Hammerschmidt F.

Bioorg Med Chem. 2009 May 1;17(9):3456-62. doi: 10.1016/j.bmc.2009.03.025. Epub 2009 Mar 19.

PMID:
19345586
42.

Bioaccumulation of polybrominated diphenyl ethers and hexabromocyclododecane in the northwest Atlantic marine food web.

Shaw SD, Berger ML, Brenner D, Kannan K, Lohmann N, Päpke O.

Sci Total Environ. 2009 May 1;407(10):3323-9. doi: 10.1016/j.scitotenv.2009.02.018. Epub 2009 Mar 9.

PMID:
19269019
43.

Specific accumulation of perfluorochemicals in harbor seals (Phoca vitulina concolor) from the northwest Atlantic.

Shaw S, Berger ML, Brenner D, Tao L, Wu Q, Kannan K.

Chemosphere. 2009 Feb;74(8):1037-43. doi: 10.1016/j.chemosphere.2008.10.063. Epub 2008 Dec 19.

PMID:
19101009
44.

Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.

Pifl C, Wolf A, Rebernik P, Reither H, Berger ML.

Neuropharmacology. 2009 Feb;56(2):531-40. doi: 10.1016/j.neuropharm.2008.10.009. Epub 2008 Oct 26.

PMID:
19000913
45.

Bioaccumulation of polybrominated diphenyl ethers in harbor seals from the northwest Atlantic.

Shaw SD, Brenner D, Berger ML, Fang F, Hong CS, Addink R, Hilker D.

Chemosphere. 2008 Dec;73(11):1773-80. doi: 10.1016/j.chemosphere.2008.09.016. Epub 2008 Oct 23.

PMID:
18950831
46.

Getting real performance out of pay-for-performance.

Nicholson S, Pauly MV, Wu AY, Murray JF, Teutsch SM, Berger ML.

Milbank Q. 2008 Sep;86(3):435-57. doi: 10.1111/j.1468-0009.2008.00528.x.

47.

The impact of consumer-directed health plans on prescription drug use.

Greene J, Hibbard J, Murray JF, Teutsch SM, Berger ML.

Health Aff (Millwood). 2008 Jul-Aug;27(4):1111-9. doi: 10.1377/hlthaff.27.4.1111.

PMID:
18607045
48.

New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.

Zolle IM, Berger ML, Hammerschmidt F, Hahner S, Schirbel A, Peric-Simov B.

J Med Chem. 2008 Apr 10;51(7):2244-53. doi: 10.1021/jm800012w. Epub 2008 Mar 19. Erratum in: J Med Chem. 2008 Dec 11;51(23):7652.

PMID:
18348518
49.

Polybrominated diphenyl ethers (PBDEs) in farmed and wild salmon marketed in the Northeastern United States.

Shaw SD, Berger ML, Brenner D, Carpenter DO, Tao L, Hong CS, Kannan K.

Chemosphere. 2008 Apr;71(8):1422-31. doi: 10.1016/j.chemosphere.2008.01.030. Epub 2008 Mar 7.

PMID:
18313722
50.

The decision to conduct a head-to-head comparative trial: a game-theoretic analysis.

Mansley EC, Elbasha EH, Teutsch SM, Berger ML.

Med Decis Making. 2007 Jul-Aug;27(4):364-79.

PMID:
17761957

Supplemental Content

Loading ...
Support Center